Okamura Yasuyoshi

Okamura Yasuyoshi | Okamura Yasuyoshi

Affiliation and department：
Research theme for competitive and other funds (2)：

2020 - 2023 Development of novel bioabsorbable metal alloy for urinary tract surgery
2017 - 2020 Genome analysis during recurrence of urothelial cancer

Papers (108)：

Jun Teishima, Takuto Hara, Taisuke Tobe, Junichiro Hirata, Hideto Ueki, Naoto Wakita, Yusuke Shiraishi, Yasuyoshi Okamura, Yukari Bando, Tomoaki Terakawa, et al. Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2024. 18. 5. E162-E166
Jun Teishima, Takuto Hara, Taisuke Tobe, Junichiro Hirata, Hideto Ueki, Naoto Wakita, Yusuke Shiraishi, Yasuyoshi Okamura, Yukari Bando, Tomoaki Terakawa, et al. The impact of primary region resection on the therapeutic outcome of combination regimens for metastatic renal cell carcinoma. Oncology letters. 2023. 26. 5. 470-470
Hideto Ueki, Tomoaki Terakawa, Yasuyoshi Okamura, Yukari Bando, Takuto Hara, Junya Furukawa, Yuzo Nakano, Masato Fujisawa. Robot-assisted laparoscopic pyeloplasty in the management of lower pole ureteropelvic junction obstruction in a patient with an incomplete duplicated collecting system. IJU case reports. 2023. 6. 6. 357-361
Taisuke Tobe, Tomoaki Terakawa, Takuto Hara, Hideto Ueki, Yusuke Shiraishi, Naoto Wakita, Yasuyoshi Okamura, Yukari Bando, Junya Furukawa, Yuzo Nakano, et al. The Efficacy of Presurgical Therapy With Avelumab and Axitinib for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus. Clinical genitourinary cancer. 2023. 21. 5. 613.e1-613.e6
Hideto Ueki, Koichi Kitagawa, Mako Kato, Shihoko Yanase, Yasuyoshi Okamura, Yukari Bando, Takuto Hara, Tomoaki Terakawa, Junya Furukawa, Yuzo Nakano, et al. An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model. Scientific reports. 2023. 13. 1. 9994-9994

ｍore...

MISC (20)：

Tomoaki Terakawa, Kotaro Suzuki, Yasuyoshi Okamura, Yukari Bando, Takuto Hara, Junya Furukawa, Kenichi Harada, Nobuyuki Hinata, Yuzo Nakano, Masato Fujisawa. Clinical outcome of EP therapy (VP16+CDDP)in 10 prostate cancer patients with neuroendocrine differentiation. INTERNATIONAL JOURNAL OF UROLOGY. 2020. 27. 74-75
Yukari Bando, Nobuyuki Hinata, Yusuke Shiraishi, Naoto Wakita, Mariko Sakamoto, Yasuyoshi Okamura, Kotaro Yuzuki, Takuto Hara, Tomoaki Terakawa, Junya Furukawa, et al. PREDICTIVE EFFICACYOF SERUMSOLUBLE PD-L1ONPATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB. JOURNAL OF UROLOGY. 2020. 203. E239-E240
原琢人, 白石祐介, 脇田直人, 坂本茉莉子, 岡村泰義, 板東由加里, 鈴木光太郎, 寺川智章, 古川順也, 原田健一, et al. 当院における腎癌患者のニボルマブとイピリムマブ併用療法の治療成績. 西日本泌尿器科. 2020. 82
Yukari Bando, Mariko Sakamoto, Yasuyoshi Okamura, Kotaro Suzuki, Takuto Hara, Tomoaki Terakawa, Junya Furukawa, Kenichi Harada, Nobuyuki Hinata, Yuzo Nakano, et al. NEUTROPHIL-TO-LYMPHOCYTE RATIO AS A PREDICTIVE BIOMARKER FOR RESPONSE TO NIVOLUMAB IN ASIAN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA. JOURNAL OF UROLOGY. 2019. 201. 4. E344-E345
古川順也, 坂本茉莉子, 岡村泰義, 板東由加里, 鈴木光太郎, 原琢人, 寺川智章, 原田健一, 日向信之, 中野雄造, et al. 淡明細胞型腎細胞癌に対するfirst-line Sunitinibの治療成績. 日本泌尿器科学会総会. 2019. 107回. OP-141

ｍore...

Lectures and oral presentations (1)：

当院における精巣腫瘍の臨床的検討
(2020)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page